跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,467 条关于
“IMC-U120AI”
全部
8,467
临床试验
1,255
药物
1,369
机构
5,434
资讯
409
8个月前
Immunocore Outlines 2026 Strategic Priorities with Focus on Melanoma Franchise Expansion and Pipeline Advancement
去年
ImmuneOncia's CD47 Antibody IMC-002 Shows 30% Response Rate in Advanced Hepatocellular Carcinoma Trial
10个月前
Immunocore's IMC-I109V Shows Promising Antiviral Activity in Phase 1 Hepatitis B Trial
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
去年
Dogwood Therapeutics Announces Financial Results and Clinical Updates for Pain and Fatigue Programs
去年
Immunocore Advances Novel Immunotherapies Targeting PRAME and PIWIL1 in Phase 1 Trials
去年
CareDx's AlloHeme Test Shows 93% Sensitivity in Early Detection of AML and MDS Relapse Post-Transplant
去年
Dogwood Therapeutics Initiates Phase 2b Trial of Halneuron® for Chemotherapy-Induced Neuropathic Pain
去年
Dogwood Therapeutics Converts $19.5M Debt to Equity, Advances Phase 2b Trial of Non-Opioid Pain Treatment
第 1 页,共 41 页
上一页
下一页